Jena, Germany, March 30, 2026 (GLOBE NEWSWIRE)-- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced ...

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to futility regarding its prespecified primary endpoint (as previously disclosed), ...

SPOKANE, Wash. — A family is pleading for help to save the life of Ryan Becker, who is fighting an extremely rare and devastating illness known as Pyoderma Gangrenosum, a condition described by ...

SPOKANE, Wash. — A Spokane father is facing a devastating choice between financial ruin and his life as he battles an extremely rare disease that requires tens of thousands in monthly medication to ...

A Malaysian woman experienced a severe facial rash months after childbirth due to pregnancy-related hormonal changes. Dermatologists highlight common skin issues during pregnancy and recommend safe ...

Recently, a video surfaced on social media by TikTok user @ayyitslala. The video, which has garnered 104 million views in just three days, shows how a Malaysian woman's skin completely changed after ...

Expert Rev Clin Pharmacol. 2010;13(4):563-580. Currently, isotretinoin is only licensed for the treatment of severe acne. However, in recent years, dermatologists have expanded their indications for ...

InflaRx N.V. (NASDAQ:IFRX) on Wednesday announced that the Independent Data Monitoring Committee (IDMC) conducting the unblinded interim analysis for the Phase 3 trial for vilobelimab in pyoderma ...

SPOKANE COUNTY, Wash. — A Spokane County man faces potential termination from his county job while he battles a rare and deadly skin disease that has kept him from working for several months. “I worry ...

Rosacea fulminans is a rare and severe inflammatory skin condition. It typically starts suddenly, and it mostly affects the central part of the face, including the chin, cheeks, and nose. Also known ...